No association of G-protein-coupled receptor kinase 5 or β-adrenergic receptor polymorphisms with Takotsubo cardiomyopathy in a large Australian cohort.
Gemma A Figtree, Richard D Bagnall, Irfan Abdulla...
https://pubmed.ncbi.nlm.nih.gov/23794609/Actively Recruiting
Led by University of Aberdeen · Updated on 2026-04-30
700
Participants Needed
2
Research Sites
N/A
Total Duration
Acute stress-induced takotsubo cardiomyopathy, also known as broken heart syndrome, mimics a heart attack and is triggered by intense emotional or physical stress. This condition can have serious and potentially fatal consequences. Researchers are studying whether certain people have a genetic predisposition that makes them more likely to develop this condition, which could also affect their families. This investigation aims to better understand the underlying causes of this complex neuro-psycho-cardiac disorder. The study involves collecting blood samples from patients diagnosed with takotsubo cardiomyopathy, including those diagnosed in Scotland since 2010 and willing familial cases worldwide. The blood will be used for genetic analysis, including a large-scale genome wide association study to identify genetic factors linked to the condition. DNA samples will be stored for future research into candidate genetic variants. Participants will provide a blood sample at baseline for genetic testing. Researchers will analyze the genetic data to identify predisposition factors through the genome wide association study. This study does not involve treatments but focuses on collecting and studying genetic information. Participation may help advance knowledge of genetic risks related to takotsubo cardiomyopathy, with involvement lasting until the baseline genetic analysis is completed.
CONDITIONS
Is There a Genetic Predisposition for Acute Stress-induced (Takotsubo) Cardiomyopathy
A
Amelia E Rudd, MSc
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University of Aberdeen
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - At baseline
Participants provide blood samples for genetic analysis to help investigate the genetic predisposition to takotsubo cardiomyopathy.
1 visit (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Gemma A Figtree, Richard D Bagnall, Irfan Abdulla...
https://pubmed.ncbi.nlm.nih.gov/23794609/Majid Nikpay, Anuj Goel, Hong-Hee Won...
https://pubmed.ncbi.nlm.nih.gov/26343387/Giorgio Caretta, Debora Robba, Enrico Vizzardi...
https://pubmed.ncbi.nlm.nih.gov/25743177/Adele H Goodloe, Jared M Evans, Sumit Middha...
https://pubmed.ncbi.nlm.nih.gov/25132214/Ingo Eitel, Christian Moeller, Matthias Munz...
https://pubmed.ncbi.nlm.nih.gov/28108127/Fridolin Sy, Jagroop Basraon, Hong Zheng...
https://pubmed.ncbi.nlm.nih.gov/23683950/Caroline Scally, Trevor Ahearn, Amelia Rudd...
https://pubmed.ncbi.nlm.nih.gov/26782339/Gautam Kumar, David R Holmes, Abhiram Prasad
https://pubmed.ncbi.nlm.nih.gov/19375184/Christopher P Nelson, Anuj Goel, Adam S Butterworth...
https://pubmed.ncbi.nlm.nih.gov/28714975/Caroline Scally, Amelia Rudd, Alice Mezincescu...
https://pubmed.ncbi.nlm.nih.gov/29128863/University of Aberdeen
Lead Sponsor